Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2001-8-14
pubmed:abstractText
Pseudomonas aeruginosa GW-1 was isolated in 2000 in South Africa from blood cultures of a 38-year-old female who developed nosocomial pneumonia. This isolate harbored a self-transferable ca. 100-kb plasmid that conferred an expanded-spectrum cephalosporin resistance profile associated with an intermediate susceptibility to imipenem. A beta-lactamase gene, bla(GES-2), was cloned from whole-cell DNA of P. aeruginosa GW-1 and expressed in Escherichia coli. GES-2, with a pI value of 5.8, hydrolyzed expanded-spectrum cephalosporins, and its substrate profile was extended to include imipenem compared to that of GES-1, identified previously in Klebsiella pneumoniae. GES-2 activity was less inhibited by clavulanic acid, tazobactam and imipenem than GES-1. The GES-2 amino acid sequence differs from that of GES-1 by a glycine-to-asparagine substitution in position 170 located in the omega loop of Ambler class A enzymes. This amino acid change may explain the extension of the substrate profile of the plasmid-encoded beta-lactamase GES-2.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-10049269, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-10103210, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-10427724, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-10602754, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-10681329, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-10722487, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-10952563, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-11036019, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-11136767, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-11257029, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-11384532, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-1311297, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-15855553, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-1662753, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-1804001, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-2039479, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-3263690, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-7486940, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-7492116, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-7695299, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-7695304, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-7783631, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-8052644, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-8092824, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-8141562, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-8181756, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-8494372, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-8517720, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-8878585, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-9037711, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-9333046, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-9333059, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-9480862, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-9521648, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502535-9738828
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2598-603
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem.
pubmed:affiliation
Service de Bactériologie-Virologie, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine Paris-Sud, 94275 Le Kremlin-Bicêtre, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't